Verified against USP, EP, CP, and FCC pharmacopeial standards. Sourced directly from our Xi'an manufacturing hub with batch-traceable COA release.
Why modern nutraceutical formulators and functional food brand owners are transitioning from delicate vegetative strains to thermodynamic Bacillus coagulans spore matrices.
Unlike vegetative species such as Lactobacillus acidophilus or Bifidobacterium bifidum, Bacillus coagulans forms a protective multilayered proteinaceous endospore coat. This natural crystalline exosporium shields the core genetic material from harsh gastric acid (pH 1.2–2.0), biliary bile salts, and digestive enzymes without requiring expensive or fragile enteric coatings.
Industrial processing destroys up to 95% of conventional vegetative probiotics during tableting compression, high-shear dry blending, hot-melt gummy confection molding, and beverage pasteurization. Bacillus coagulans endospores withstand extreme mechanical shear pressures up to 300 MPa and thermal processing environments exceeding 90°C–100°C.
Traditional probiotics demand continuous sub-zero or refrigerated cold chains (-20°C to 4°C) across ocean freight, port transshipment, warehousing, and retail shelves. Bacillus coagulans spore powder remains biochemically dormant and thermally inert at ambient room temperatures (25°C, 60% RH) for up to 36 months, drastically lowering transport loss and demurrage risk.
From pure-strain master banks to low-temperature spray drying, our production pipeline integrates advanced solid-state and submerged fermentation controls.
Strains validated through 16S rRNA gene sequencing and whole-genome profiling. Absolutely screened for antibiotic resistance gene transferability, hemolytic activity, and absence of enterotoxigenic factors.
Microprocessor-controlled stainless steel bioreactors monitor dissolved oxygen (DO), pH, agitation velocity, and nitrogen feed rates to induce synchronized, maximum-efficiency sporulation yields above 98%.
Employing fluidized-bed and controlled inlet/outlet low-temperature spray drying with carrier-free or clean-label maltodextrin/inulin vectors, ensuring structural membrane integrity and rapid hydration reconstitutability.
Available in concentrated bulk pure powder or custom-standardized potencies (5B to 200B CFU/g). Homogenized in cleanroom Class 100,000 environments to prevent cross-contamination and moisture absorption.
| Analytical Parameter | Technical Specification Target | Analytical Method Reference | Compliance Relevance |
|---|---|---|---|
| Identity & Morphology | Gram-positive, spore-forming rod-shaped bacterium | Microscopic examination & 16S rRNA sequencing | Confirms genuine B. coagulans strain identity |
| Viable Cell Count (Potency) | 5.0 × 10¹⁰ CFU/g (50 Billion) or customized 10B–200B | Serial dilution plate count (FCC / USP monograph) | Guarantees active dosage potency per gram |
| Sporulation Rate | ≥ 98.0% total count | Spore stain / Heat inactivation ratio (80°C, 10 min) | Directly correlates to thermal and acid survivability |
| Water Activity (Aw) | ≤ 0.20 Aw (Moisture ≤ 6.0%) | Chilled-mirror dewpoint sensor / Halogen moisture | Inhibits premature germination and maintains shelf-life |
| Particle Granulometry | 80–100 Mesh (100% pass through standard sieve) | USP <786> Particle Size Distribution Analytical | Ensures frictionless uniform blending in capsules/tablets |
| Heavy Metals (Pb, As, Cd, Hg) | Pb ≤ 0.5 ppm, As ≤ 0.5 ppm, Cd ≤ 0.1 ppm, Hg ≤ 0.1 ppm | ICP-MS (Inductively Coupled Plasma Mass Spectrometry) | Exceeds strict USP <2232> and California Prop 65 limits |
| Microbiological Contaminants | E. coli: Neg/10g; Salmonella: Neg/25g; S. aureus: Neg/10g | USP <2021>, <2022> / BAM FDA Bacteriological Manual | Guarantees clean pathogenic safety across global ports |
Engineering flexible, bioactive ingredient solutions capable of surviving real-world manufacturing shear, heat, and moisture environments.
Traditional probiotics fail in hot tea, coffee, and ambient acidic beverages (pH 3.0–4.5). Bacillus coagulans powder dissolves cleanly into pre-workout formulations, kombucha concentrates, and instant protein powders without losing viable cell counts over prolonged container shelf lives.
Gummy manufacturing involves cooking pectin or gelatin slurries at 105°C–120°C and setting at high brix levels. Our microencapsulated spore preparations maintain greater than 90% survival rates throughout the deposition cooling tunnel, enabling verified label claims in nutritional gummies, granola bars, and baked breakfast goods.
Engineered for enteric capsules, two-piece hard gelatin capsules, and direct-compression tableting. Works in synergy with prebiotics (FOS, GOS, resistant dextrin) and natural active enzymes (lactase, papain, bromelain) to promote microbial balance, alleviate occasional abdominal discomfort, and support post-antibiotic microbiome recovery.
Simplifying market entry across North America, the European Union, the Middle East, and the Asia-Pacific region through complete documentation transparency.
Manufactured under cGMP (21 CFR Part 111 & Part 117). Full support for US FDA FSMA Foreign Supplier Verification Programs (FSVP), structure/function substantiation dossiers, and GRAS status qualification files.
Complies with EFSA Qualified Presumption of Safety (QPS) guidelines. Certified free of toxigenic genes, negative for acquired antimicrobial resistance genes via whole-genome mapping, and compliant with EU heavy metal regulation limits.
Certified by recognized international Islamic bodies and Rabbinical authorities. 100% vegetarian fermentation media free of porcine, bovine, or dairy derivatives, opening unrestricted access to Middle Eastern and SE Asian markets.
Every shipment is backed by verified batch-specific COA, technical data sheets (TDS), safety data sheets (MSDS), allergen-free statements, BSE/TSE-free certificates, non-GMO declarations, and validated stability studies.
How our R&D center in Xi'an is pushing the frontiers of functional synbiotics, metabolic yield optimization, and AI-guided fermentation analytics.
Industrial optimization of submerged fermentation media achieving over 98% endospore formation rate, producing raw bulk yields scaling up to 200 Billion CFU/g with low moisture activity.
Applying lipidic-polysaccharide enteric bilayers on raw spores to expand survival under extreme continuous pasteurization (121°C, 30s) and carbonated acidic beverage canning environments.
Formulating targeted co-cultures combining Bacillus coagulans with specific plant polyphenols (quercetin, green tea catechins) and bioactive peptides to enhance intestinal mucosal repair.
Heat-inactivated paraprobiotics and concentrated endospore cell-wall fractions rich in peptidoglycans and teichoic acids for sterile cosmetic topical creams and functional beverage clarity.
Addressing the core technical, formulation, and regulatory questions raised by global contract manufacturers and pharmaceutical procurement directors.
Integrate our specialty ingredients into consolidated container shipments to streamline supplier qualification and freight economics.